Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 3 h ago

ABEONA THERAPEUTICS INC.: TPG GP A, LLC discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

TPG GP A, LLC disclosed a stake exceeding 5% in Abeona Therapeutics Inc. via a Schedule 13G filing with the SEC (accession 0001999371-26-025509). The filing signals that the private equity firm has crossed the threshold that triggers passive-investor reporting obligations. The exact share count and percentage were not specified in the headline disclosure. The move matters because a TPG affiliate holding a meaningful block can influence Abeona's shareholder base and governance dynamics. Next, watch for the full 13G to confirm the precise stake size and any subsequent amendments reflecting changes in TPG's position.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Abeona Therapeutics Inc., TPG GP A, LLC